TCR-engineered T-cells directed against Ropporin-1 constitute a safe and effective treatment for triple-negative breast cancer

Overview of attention for article published in Cancer Discovery, August 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

So far, Altmetric has seen 3 news stories from 3 outlets.

Listen with Speechify Register for free to listen to this article Thank you. Listen to this article using the player above.

Leiden researchers have developed a model to advance cancer immunotherapy. Using a 3D printer, they create mini-tumors within…

Leiden researchers have developed a groundbreaking model to advance cancer immunotherapy.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.